Company registration number 09306240 (England and Wales)
Majesticare (Evesham) Holdings Limited
Annual report and financial statements
For the year ended 30 September 2025
Majesticare (Evesham) Holdings Limited
Company information
Directors
Mr S C Oakes
Mr R W M Pratap
Mrs A Boxall
Company number
09306240
Registered office
Nova House
2 Hall Farm Way
Smalley
Ilkeston
DE7 6JS
Auditor
DJH Audit Limited
The Glades
Festival Way
Festival Park
Stoke-on-Trent
Staffordshire
ST1 5SQ
Majesticare (Evesham) Holdings Limited
Contents
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 7
Statement of comprehensive income
8
Statement of financial position
9
Statement of changes in equity
10
Notes to the financial statements
11 - 17
Majesticare (Evesham) Holdings Limited
Strategic report
For the year ended 30 September 2025
- 1 -

The directors present the strategic report for the year ended 30 September 2025.

Review of the business

The directors aim to present a balanced and comprehensive review of the development and performance of their business during the year and its position at the end of the year. The review is consistent with the size and non-complex nature of the business and is written in the context of the risks and uncertainties they face.

There has been no turnover in the period, with the company continuing its activities as a holding company.

Profits after taxation in 2025 are £14,077 which is an increase on the loss of £83,379 in 2024. This increase is due to there being no interest payable on the intercompany balances, as they have now been cleared.

At the balance sheet date net assets decreased from £1,768,584 in 2024 to £1,333,305 in 2025, as a result of the majority of the intercompany debtors being repaid in the year.

Principal risks and uncertainties

Due to the nature of the company being a holding company, it does not directly have any principal risks or uncertainties.

The company could be affected, however if its subsidiary company trade is impacted for any given reason.

The trade company continues to experience a healthy level of residents in the care home and is not forecasting any significant reductions in sales or profitability. As a result, the company is not considered to be any major risk from any possible downturn in the trade of the subsidiary company.

Financial instrument risks

The only financial instruments that the company has are amounts owed to and from group undertakings.

Future developments

Overall the accounts should be similar to the previous year and hence the directors are confident that the going concern basis is appropriate for the preparation of the accounts due to support from the other group companies.

Key performance indicators

The directors consider that the key financial performance indicators are net profit and net profit margin:

Net profit/loss - £14,077 Profit (2024 - £83,379 Loss).

Net profit/loss is profit after tax.

On behalf of the board

Mr S C Oakes
Director
26 March 2026
Majesticare (Evesham) Holdings Limited
Directors' report
For the year ended 30 September 2025
- 2 -

The directors present their annual report and financial statements for the year ended 30 September 2025.

Principal activities

The principal activity of the company continued to be that of a holding company.

Results and dividends

The results for the year are set out on page 8.

Ordinary dividends were paid amounting to £449,356 (2024: £Nil). The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr S C Oakes
Mr R W M Pratap
Mrs A Boxall
Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Majesticare (Evesham) Holdings Limited
Directors' report (continued)
For the year ended 30 September 2025
- 3 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
Mr S C Oakes
Director
26 March 2026
Majesticare (Evesham) Holdings Limited
Independent auditor's report
To the members of Majesticare (Evesham) Holdings Limited
- 4 -
Opinion

We have audited the financial statements of Majesticare (Evesham) Holdings Limited (the 'company') for the year ended 30 September 2025 which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 30 September 2025 and of its profit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Majesticare (Evesham) Holdings Limited
Independent auditor's report (continued)
To the members of Majesticare (Evesham) Holdings Limited
- 5 -

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

- the information given in the strategic report and the directors' r eport for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identifie d material misstatements in the strategic report or the directors' r eport.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

- the financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' r esponsibilities s tatement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Majesticare (Evesham) Holdings Limited
Independent auditor's report (continued)
To the members of Majesticare (Evesham) Holdings Limited
- 6 -

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

- the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;

- we identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the company;

- we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and

- identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and

- considering the internal controls in place to mitigate risks of fraud and non compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:

- performed analytical procedures to identify any unusual or unexpected relationships;

- tested journal entries to identify unusual transactions; and

- assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

- agreeing financial statement disclosures to underlying supporting documentation;

- enquiring of management as to actual and potential litigation and claims; and

- reviewing correspondence with HMRC, relevant regulators including the Health and Safety Executive, Care Quality Commission and the company’s legal advisors.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Majesticare (Evesham) Holdings Limited
Independent auditor's report (continued)
To the members of Majesticare (Evesham) Holdings Limited
- 7 -

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Gary Chadwick FCCA
Senior Statutory Auditor
For and on behalf of DJH Audit Limited
26 March 2026
Accountants
Statutory Auditor
The Glades
Festival Way
Festival Park
Stoke-on-Trent
Staffordshire
ST1 5SQ
Majesticare (Evesham) Holdings Limited
Statement of comprehensive income
For the year ended 30 September 2025
- 8 -
2025
2024
Notes
£
£
Turnover
-
-
Administrative expenses
(4,200)
-
0
Operating loss
(4,200)
-
Interest receivable and similar income
4
18,277
-
0
Interest payable and similar expenses
5
-
0
(256,819)
Profit/(loss) before taxation
14,077
(256,819)
Tax on profit/(loss)
6
-
0
173,440
Profit/(loss) for the financial year
14,077
(83,379)
Majesticare (Evesham) Holdings Limited
Statement of financial position
As at 30 September 2025
- 9 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
8
1
1
Current assets
Debtors
10
1,333,304
10,375,138
Creditors: amounts falling due within one year
11
-
0
(3,850,000)
Net current assets
1,333,304
6,525,138
Total assets less current liabilities
1,333,305
6,525,139
Creditors: amounts falling due after more than one year
12
-
0
(4,756,555)
Net assets
1,333,305
1,768,584
Capital and reserves
Called up share capital
14
1,000,000
1,000,000
Profit and loss reserves
333,305
768,584
Total equity
1,333,305
1,768,584

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 26 March 2026 and are signed on its behalf by:
Mr S C Oakes
Director
Company registration number 09306240 (England and Wales)
Majesticare (Evesham) Holdings Limited
Statement of changes in equity
For the year ended 30 September 2025
- 10 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 October 2023
1,000,000
851,963
1,851,963
Year ended 30 September 2024:
Loss and total comprehensive income
-
(83,379)
(83,379)
Balance at 30 September 2024
1,000,000
768,584
1,768,584
Year ended 30 September 2025:
Profit and total comprehensive income
-
14,077
14,077
Dividends
7
-
(449,356)
(449,356)
Balance at 30 September 2025
1,000,000
333,305
1,333,305
Majesticare (Evesham) Holdings Limited
Notes to the financial statements
For the year ended 30 September 2025
- 11 -
1
Accounting policies
Company information

Majesticare (Evesham) Holdings Limited is a private company limited by shares incorporated in England and Wales. The registered office is Nova House, 2 Hall Farm Way, Smalley, Ilkeston, DE7 6JS.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. T he company has therefore taken advantage of e xemptions from the following disclosure requirements:

- Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

- Section 11 ‘Basic Financial Instruments’

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

Majesticare (Evesham) Holdings Limited is a wholly owned subsidiary of Majesticare Ltd and the results of Majesticare (Evesham) Holdings Limited are included in the consolidated financial statements of Majesticare Ltd which are publicly available.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

Majesticare (Evesham) Holdings Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
1
Accounting policies
(Continued)
- 12 -
1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Majesticare (Evesham) Holdings Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
1
Accounting policies
(Continued)
- 13 -
Basic financial liabilities

Basic financial liabilities are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

Majesticare (Evesham) Holdings Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
- 14 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The directors consider that there are no critical judgements, key estimates or assumptions used in preparing the financial statements.

3
Employees

The average monthly number of persons employed by the company during the year was nil (2024 - nil)

4
Interest receivable and similar income
2025
2024
£
£
Income from fixed asset investments
Income from shares in group undertakings
18,277
-
0
5
Interest payable and similar expenses
2025
2024
£
£
Interest payable to group undertakings
-
0
256,819
Majesticare (Evesham) Holdings Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
- 15 -
6
Taxation
2025
2024
£
£
Deferred tax
Origination and reversal of timing differences
-
0
(173,440)

The actual charge/(credit) for the year can be reconciled to the expected charge/(credit) for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Profit/(loss) before taxation
14,077
(256,819)
Expected tax charge/(credit) based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
3,519
(64,205)
Tax effect of income not taxable in determining taxable profit
(4,569)
-
0
Unutilised tax losses carried forward
1,050
(173,440)
Group relief
-
0
64,205
Taxation charge/(credit) for the year
-
(173,440)
7
Dividends
2025
2024
£
£
Final paid
449,356
-
0
8
Fixed asset investments
2025
2024
Notes
£
£
Investments in subsidiaries
9
1
1
Majesticare (Evesham) Holdings Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
- 16 -
9
Subsidiaries

Details of the company's subsidiaries at 30 September 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Indirect
Majesticare (Evesham) Limited
Nova House Hall Farm Way, Smalley, Ilkeston, England, DE7 6JS
Ordinary
100
-
Majesticare Cavendish Limited
Nova House Hall Farm Way, Smalley, Ilkeston, England, DE7 6JS
Ordinary
0
100
10
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
-
0
2,250,000
2025
2024
Amounts falling due after more than one year:
£
£
Amounts owed by group undertakings
1,159,864
7,951,698
Deferred tax asset (note 13)
173,440
173,440
1,333,304
8,125,138
Total debtors
1,333,304
10,375,138
11
Creditors: amounts falling due within one year
2025
2024
£
£
Dividends payable
-
0
3,850,000
12
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
-
0
4,756,555
Majesticare (Evesham) Holdings Limited
Notes to the financial statements (continued)
For the year ended 30 September 2025
- 17 -
13
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Assets
Assets
2025
2024
Balances:
£
£
Tax losses
173,440
173,440
There were no deferred tax movements in the year.
14
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary 'A' shares of £1 each
750,000
750,000
750,000
750,000
Ordinary 'B' shares of £1 each
250,000
250,000
250,000
250,000
1,000,000
1,000,000
1,000,000
1,000,000
15
Ultimate controlling party

The ultimate parent company is Majesticare Ltd, incorporated in England and Wales, registered office, Nova House Hall Farm Way, Smalley, Ilkeston, England, DE7 6JS

Mr R W M Pratap is the ultimate controlling party, by virtue of his shareholding in the ultimate holding company.

The largest and smallest group in which the results of the company are consolidated is that headed by Majesticare Limited, incorporated in England and Wales. The consolidated accounts of this company are available to the public and may be obtained from Companies House, Crown Way, Cardiff, CF14 3UZ. No other group accounts included the results of the company.

2025-09-30 2024-10-01 false false false CCH Software CCH Accounts Production 2025.300 Mr S C Oakes Mr R W M Pratap Mrs A Boxall 0 09306240 2024-10-01 2025-09-30 09306240 bus:Director1 2024-10-01 2025-09-30 09306240 bus:Director2 2024-10-01 2025-09-30 09306240 bus:Director3 2024-10-01 2025-09-30 09306240 bus:RegisteredOffice 2024-10-01 2025-09-30 09306240 2025-09-30 09306240 2023-10-01 2024-09-30 09306240 core:RetainedEarningsAccumulatedLosses 2023-10-01 2024-09-30 09306240 core:RetainedEarningsAccumulatedLosses 2024-10-01 2025-09-30 09306240 2024-09-30 09306240 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 09306240 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 09306240 core:Non-currentFinancialInstruments core:AfterOneYear 2025-09-30 09306240 core:Non-currentFinancialInstruments core:AfterOneYear 2024-09-30 09306240 core:ShareCapital 2025-09-30 09306240 core:ShareCapital 2024-09-30 09306240 core:RetainedEarningsAccumulatedLosses 2025-09-30 09306240 core:RetainedEarningsAccumulatedLosses 2024-09-30 09306240 core:ShareCapital 2023-09-30 09306240 core:RetainedEarningsAccumulatedLosses 2023-09-30 09306240 core:ShareCapitalOrdinaryShareClass1 2025-09-30 09306240 core:ShareCapitalOrdinaryShareClass1 2024-09-30 09306240 core:ShareCapitalOrdinaryShareClass2 2025-09-30 09306240 core:ShareCapitalOrdinaryShareClass2 2024-09-30 09306240 core:ShareCapitalOrdinaryShares 2025-09-30 09306240 core:ShareCapitalOrdinaryShares 2024-09-30 09306240 core:UKTax 2024-10-01 2025-09-30 09306240 core:UKTax 2023-10-01 2024-09-30 09306240 core:Non-currentFinancialInstruments 2025-09-30 09306240 core:Non-currentFinancialInstruments 2024-09-30 09306240 core:Subsidiary1 2024-10-01 2025-09-30 09306240 core:Subsidiary2 2024-10-01 2025-09-30 09306240 core:Subsidiary1 1 2024-10-01 2025-09-30 09306240 core:Subsidiary2 2 2024-10-01 2025-09-30 09306240 core:CurrentFinancialInstruments 2025-09-30 09306240 core:CurrentFinancialInstruments 2024-09-30 09306240 core:AfterOneYear 2025-09-30 09306240 core:AfterOneYear 2024-09-30 09306240 core:Non-currentFinancialInstruments 1 2025-09-30 09306240 core:Non-currentFinancialInstruments 1 2024-09-30 09306240 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 09306240 bus:OrdinaryShareClass2 2024-10-01 2025-09-30 09306240 bus:OrdinaryShareClass1 2025-09-30 09306240 bus:OrdinaryShareClass1 2024-09-30 09306240 bus:OrdinaryShareClass2 2025-09-30 09306240 bus:OrdinaryShareClass2 2024-09-30 09306240 bus:AllOrdinaryShares 2025-09-30 09306240 bus:AllOrdinaryShares 2024-09-30 09306240 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 09306240 bus:FRS102 2024-10-01 2025-09-30 09306240 bus:Audited 2024-10-01 2025-09-30 09306240 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP